1. AB0431 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data. (15th June 2017) Authors: Mimori, T; Harigai, M; Atsumi, T; Kuwana, M; Takei, S; Tamura, N; Fujii, T; Matsuno, H; Momohara, S; Yamamoto, K; Kokubo, T; Endo, Y; Sugiyama, N; Hirose, T; Morishima, Y; Yoshii, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0191 Effects of tofacitinib, an oral janus kinase inhibitor, on patient-reported outcomes in japanese patients with rheumatoid arthritis. (15th June 2017) Authors: Yamanaka, H; Tanaka, Y; Takeuchi, T; Sugiyama, N; Hirose, T; Yoshii, N; Morishima, Y; Toyoizumi, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗